Clinical Trials Browser

Phase 2/3 × INDUSTRY × XELOX × Clear all

NCT02510118 2015-08-03

Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients

Phase 2/3 Unknown

Gastrointestinal

Colonic Neoplasms